Search research articles
Contact Us
Filters
Showing results (871-880 of 908) with videos related to
Page
of 91
Sort By:
Epigenetics & Chromatin
|
June 8, 2011
Generation of bivalent chromatin domains during cell fate decisions
Marco De Gobbi, David Garrick, Magnus Lynch, et al.
Human Molecular Genetics
|
May 7, 2009
Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23
Gisela Orozco, Anne Hinks, Steve Eyre, et al.
Human Mutation
|
October 17, 2013
Variant ATRX syndrome with dysfunction of ATRX and MAGT1 genes
Ying Qiao, Kajari Mondal, Valentina Trapani, et al.
The Journal of Clinical Investigation
|
January 2, 2025
ATRX silences Cartpt expression in osteoblastic cells during skeletal development
Yi-Ting Chen, Ming-Ming Jiang, Carolina Leynes, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 18, 2009
Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract
Pedro J Gomez-Pinilla, Simon J Gibbons, Michael R Bardsley, et al.
Drug and Alcohol Dependence
|
June 7, 2025
HEALing Communities Study: Data measures for supporting a community-based intervention to reduce opioid overdose deaths
Svetla Slavova, Jennifer Villani, Daniel J Feaster, et al.
Cancer Research
|
July 9, 2009
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin
Ker Yu, Lourdes Toral-Barza, Celine Shi, et al.
Molecular Cancer Therapeutics
|
November 9, 2007
Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT/PKB: mechanistic involvement of AKT catalytic activation loop cysteines
Lourdes Toral-Barza, Wei-Guo Zhang, Xinyi Huang, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
April 28, 2012
Nprl3 is required for normal development of the cardiovascular system
Monika S Kowalczyk, Jim R Hughes, Christian Babbs, et al.
Journal of Medicinal Chemistry
|
August 4, 2009
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines
Arie Zask, Jeroen C Verheijen, Kevin Curran, et al.
Page
of 91
Search research articles
Search
Showing results (871-880 of 908) with videos related to
Sort By:
Page
of 91
Epigenetics & Chromatin
|
June 8, 2011
Generation of bivalent chromatin domains during cell fate decisions
Marco De Gobbi, David Garrick, Magnus Lynch, et al.
Human Molecular Genetics
|
May 7, 2009
Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23
Gisela Orozco, Anne Hinks, Steve Eyre, et al.
Human Mutation
|
October 17, 2013
Variant ATRX syndrome with dysfunction of ATRX and MAGT1 genes
Ying Qiao, Kajari Mondal, Valentina Trapani, et al.
The Journal of Clinical Investigation
|
January 2, 2025
ATRX silences Cartpt expression in osteoblastic cells during skeletal development
Yi-Ting Chen, Ming-Ming Jiang, Carolina Leynes, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 18, 2009
Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract
Pedro J Gomez-Pinilla, Simon J Gibbons, Michael R Bardsley, et al.
Drug and Alcohol Dependence
|
June 7, 2025
HEALing Communities Study: Data measures for supporting a community-based intervention to reduce opioid overdose deaths
Svetla Slavova, Jennifer Villani, Daniel J Feaster, et al.
Cancer Research
|
July 9, 2009
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin
Ker Yu, Lourdes Toral-Barza, Celine Shi, et al.
Molecular Cancer Therapeutics
|
November 9, 2007
Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT/PKB: mechanistic involvement of AKT catalytic activation loop cysteines
Lourdes Toral-Barza, Wei-Guo Zhang, Xinyi Huang, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
April 28, 2012
Nprl3 is required for normal development of the cardiovascular system
Monika S Kowalczyk, Jim R Hughes, Christian Babbs, et al.
Journal of Medicinal Chemistry
|
August 4, 2009
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines
Arie Zask, Jeroen C Verheijen, Kevin Curran, et al.
Page
of 91